Equities research analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the stock.
SenesTech Stock Performance
SenesTech stock opened at $2.50 on Friday. The company has a fifty day simple moving average of $3.86 and a 200 day simple moving average of $5.93. SenesTech has a 1-year low of $1.90 and a 1-year high of $78.00. The company has a quick ratio of 3.49, a current ratio of 4.68 and a debt-to-equity ratio of 0.05.
SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. The business had revenue of $0.46 million during the quarter, compared to analysts’ expectations of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same quarter last year, the company posted ($84.03) earnings per share.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- How to buy stock: A step-by-step guide for beginners
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is an Earnings Surprise?
- MarketBeat Week in Review – 9/16 – 9/20
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
